Equities

Jacobio Pharmaceuticals Group Co Ltd

Jacobio Pharmaceuticals Group Co Ltd

Actions
  • Price (HKD)1.77
  • Today's Change-0.02 / -1.12%
  • Shares traded1.13m
  • 1 Year change-57.86%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,1431,2841,538
Total Receivables, Net214098
Total Inventory------
Prepaid expenses------
Other current assets, total4.72154.55
Total current assets1,1681,3391,640
Property, plant & equipment, net22020542
Goodwill, net------
Intangibles, net1.371.021.55
Long term investments682516
Note receivable - long term2.914.2320
Other long term assets--02.86
Total assets1,4601,5751,722
LIABILITIES
Accounts payable819751
Accrued expenses182519
Notes payable/short-term debt7400
Current portion long-term debt/capital leases14134.92
Other current liabilities, total18215.72
Total current liabilities20515681
Total long term debt1221351.89
Total debt2101486.81
Deferred income tax------
Minority interest--00
Other liabilities, total601.612.02
Total liabilities38729285
SHAREHOLDERS EQUITY
Common stock0.520.510.51
Additional paid-in capital------
Retained earnings (accumulated deficit)1,0731,2821,637
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.240.16(0.14)
Total equity1,0731,2831,637
Total liabilities & shareholders' equity1,4601,5751,722
Total common shares outstanding792771771
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.